Overview


According to FutureWise analysis the market for Lateral Flow Assays in 2023 is US$ 9.59 billion, and is expected to reach US$ 14.08 billion by 2031 at a CAGR of 4.92%.

Lateral flow is a type of immunoassay that uses a paper-based strip to detect the presence of a specific target analyte, such as a virus or a protein biomarker, in a biological sample. The sample is usually applied to one end of the strip, and the strip contains various antibodies that bind to the target analyte if it is present. The strip is then read visually, with the appearance of a line indicating the presence of the analyte. The lateral flow market includes various applications such as infectious disease testing, pregnancy testing, drug testing, and others. Detecting the presence (or absence) of a target analyte in a sample is done using lateral flow assays, also recognised as lateral flow immunochromatographic assay. For the qualitative and quantitative identification of particular antigens and antibodies, these tests are frequently employed in hospitals and clinical laboratories.

FutureWise Market Research has published a report that provides an insightful analysis of Lateral Flow Assays Market trends that are affecting the overall market growth. This report will provide a detailed analysis of market share, regional insights, and competitor analysis that includes stature of key manufacturers operational in this industry. By the end of the forecast period FutureWise research analysts projects that Lateral Flow Assays Market will experience a significant growth. According to the analysis done, this report will help understand the information referring to the total valuation held by this industry. Additionally, this report will help in understanding the growth opportunities held by various segments of this market, further assist in making better strategic and expansion decisions by key stakeholders of an organization.
  • Abbott Laboratories
  • F. Hoffman-La Roche Ltd.
  • Danaher Corporation
  • Siemens AG
  • Becton, Dickinson and Company
  • bioMérieux SA
  • Bio-Rad Laboratories
  • Thermo Fisher Scientific, Inc.
  • PerkinElmer Inc.
  • Hologic Inc.
  • Qiagen N.V.
  • Quidel Corporation
  • Merck KGaA
  • Abcam plc
  • Surmodics IVD
  • Chembio Diagnostic Systems, Inc.
  • OraSure Technologies
  • DCN Diagnostics
  • Polysciences, Inc.
  • Abingdon Health
  • BioPorto Diagnostics A/S
  • Microcoat Biotechnologie GmbH
  • Scienion AG
  • Senova GmbH
  • Access Bio, Inc.

(Note: The list of the major players will be updated with the latest market scenario and trends)

Recent developments by key players in Lateral Flow Assays Market:

In October 2022, Roche Diagnostics introduced SARS-CoV-2 Rapid Antigen Test 2.0 Nasal3, the SARS-CoV-2 Rapid Antigen Test 2.01 and SARS-CoV-2 Rapid Antigen Test 2.0 Nasal2.

The Lateral Flow Assays market is a significant and growing sector in the medical industry. Lateral flow technology is widely used in point-of-care diagnostic tests for a range of applications, including infectious diseases, pregnancy testing, drug testing, and more.

In recent years, there has been a significant increase in demand for lateral flow technology due to advancements in technology, increased awareness, and a growing global population. One major factor affecting the dynamics of Lateral Flow Assays market is the level of competition. The lateral flow market is extremely competitive, with many established players and newcomers competing for market share. The competition is fueled by the growing demand for point-of-care testing, with many companies investing in R&D to improve the accuracy and efficiency of lateral flow tests. Additionally, the Lateral Flow Assays markets are subject to various regulations and approvals before their products can be marketed and sold. The stringent regulatory requirements can make it challenging for new competitors to establish themselves in the market, while established players have an advantage due to their resources and experience. Furthermore, the Lateral Flow Assays market is anticipated to expand significantly in the coming years due to the aging population and increasing awareness of the importance of early cancer diagnosis.

By Product

  • Kits And Reagents
  • Lateral Flow Readers
    • Digital/Handheld Readers
    • Benchtop Readers
    • Mobile/Smartphone Readers

By Application

  • Clinical Testing
    • Infectious Disease Testing
      • Mosquito-borne Diseases
      • Covid-19
      • Influenza
      • Sexually Transmitted Infections
        • HIV
        • HPV
        • Chlamydia
        • Gonorrhea
        • Syphilis
        • Other Sexually Transmitted Infections
      • Hepatitis
      • Tuberculosis
      • Other Infectious Diseases
    • Cardiac Marker Testing
      • Troponin I and T Testing
      • CK-MB Testing
      • BNP or NT-proBNP Testing
      • Myoglobin Testing
      • D-Dimer Testing
      • Other Cardiac Markers
    • Pregnancy And Fertility Testing
      • Pregnancy Testing
      • Fertility Testing
    • Cholesterol Testing/Lipid Profiles
    • Drugs-of-Abuse Testing
  • Veterinary Diagnostics
  • Food Safety And Environment Testing
  • Drug Development And Quality Testing

By Technique

  • Sandwich Assays
  • Competitive Assays
  • Multiplex Detection Assays

By Sample Type

  • Blood Samples
  • Urine Samples
  • Saliva Samples
  • Other Samples

By End User

  • Hospitals And Clinics
  • Diagnostic Laboratories
  • Home Care Settings
  • Pharmaceutical And Biotechnology Companies
  • Other End Users

By Region

  • North America
  • Europe
  • Asia-Pacific
  • Latin America
  • Middle East and Africa

This market research report also emphasis on factors affecting the growth rate in various regions listed above. A deep-down analysis of region will also be provided in the final version of this market which is based on conclusion of primary interviews and secondary data point gathered during the process.

By region, the market is segmented into North America, Latin America, Europe, Asia-Pacific, and Middle East & Africa. North America registered highest share in the market in 2022. The second most common cancer-related cause of mortality in American males is prostate cancer, according to the American Society of Clinical Oncology. Additional factors that are anticipated to drive the regional market include improvements in healthcare and a greater emphasis on prostate cancer diagnosis by the government. A significant element fostering market expansion is the sheer number of major players in North America. Additionally, based on application, clinical testing segment holds highest market share in 2022 globally.


  • Tier 1 players- established companies in the market with a major market share
  • Tier 2 players
  • Emerging players which are growing rapidly
  • New Entrants
  • Growth prospects
  • SWOT analysis
  • Key trends
  • Key data-points affecting market growth
  • To provide with an exhaustive analysis on the Lateral Flow Assays Market By Product, By Application, By Technique, By Sample Type, By End User and By Region.
  • To cater comprehensive information on factors impacting market growth (drivers, restraints, opportunities, and industry-specific restraints)
  • To evaluate and forecast micro-markets and the overall market
  • To predict the market size, in key regions— North America, Europe, Asia Pacific, Latin America and Middle East and Africa.
  • To record and evaluate competitive landscape mapping- product launches, technological advancements, mergers and expansions
  • We have a flexible delivery model and you can suggest changes in the scope/table of content as per your requirement
  • The customization Mobility Care offered are free of charge with purchase of any license of the report
  • You can directly share your requirements/changes to the current table of content to: sales@futurewiseresearch.com

Table of Contents


  • 1.   Market Introduction
    •   1. Objectives of the Study
        2. Market Definition
        3. Market Scope
         3.1. Years Considered for the Study
         3.2. Market Covered
        4. Currency
        5. Limitations
        6. Stakeholders
  • 2.   Research Methodology
    •   1. Research Data
         1.1. Secondary Data
          1.1.1. Key Data from Secondary Sources
         1.2. Primary Data
          1.2.1. Key Data from Primary Sources
        2. Market Size Estimation
        3. Market Breakdown and Data Triangulation
        4. Assumptions for the Study
  • 3.   Executive Summary
    •   1. Market Outlook
        2. Segment Outlook
        3. Competitive Insights
  • 4.   Lateral Flow Assays Market Variables, Trends and Scope

    •   1. Market Lineage Outlook
        2. Penetration and Growth Prospect Mapping
        3. Industry Value Chain Analysis
        4. Cost Analysis Breakdown
        5. Technology Overview
        6. Regulatory Framework
         6.1. Reimbursement Framework
         6.2. Standards and Compliances

  • 5.   Market Overview
    •   1. Market Dynamics
         1.1. Market Driver Analysis
          1.1.1. Increasing focus of Lateral Flow Assays Market Companies on Brand Protection
          1.1.2. Untapped Opportunities in Emerging Regions
         1.2. Market Restraint Analysis
          1.2.1. High Cost Associated with Implementation of Predictive Analysis
         1.3. Industry Challenges
          1.3.1. Presence of Ambiguous Regulatory Framework
  • 6.   Lateral Flow Assays Market Analysis Tools
    •   1. Industry Analysis - Porter’s
         1.1. Supplier Power
         1.2. Buyer Power
         1.3. Substitution Threat
         1.4. Threat from New Entrants
         1.5. Competitive Rivalry
        2. Pestel Analysis
         2.1. Political Landscape
         2.2. Environmental Landscape
         2.3. Social Landscape
         2.4. Technology Landscape
         2.5. Legal Landscape
        3. Major Deals And Strategic Alliances Analysis
         3.1. Joint Ventures
         3.2. Mergers and Acquisitions
         3.3. Licensing and Partnership
         3.4. Technology Collaborations
         3.5. Strategic Divestments
        4. Market Entry Strategies
        5. Case Studies
  • 7.   Lateral Flow Assays Market, By Product Historical Analysis and Forecast 2023-2031 (USD Million)

    •   1. Kits And Reagents
        2. Lateral Flow Readers
         2.1. Digital/Handheld Readers
         2.2. Benchtop Readers
         2.3. Mobile/Smartphone Readers

  • 8.   Lateral Flow Assays Market, By Application Historical Analysis and Forecast 2023-2031 (USD Million)

    •   1. Clinical Testing
         1.1. Infectious Disease Testing
          1.1.1. Mosquito-borne Diseases
          1.1.2. Covid-19
          1.1.3. Influenza
          1.1.4. Sexually Transmitted Infections
           1.1.4.1. HIV
           1.1.4.2. HPV
           1.1.4.3. Chlamydia
           1.1.4.4. Gonorrhea
           1.1.4.5. Syphilis
           1.1.4.6. Other Sexually Transmitted Infections
          1.1.5. Hepatitis
          1.1.6. Tuberculosis
          1.1.7. Other Infectious Diseases
         1.2. Cardiac Marker Testing
          1.2.1. Troponin I and T Testing
          1.2.2. CK-MB Testing
          1.2.3. BNP or NT-proBNP Testing
          1.2.4. Myoglobin Testing
          1.2.5. D-Dimer Testing
          1.2.6. Other Cardiac Markers
         1.3. Pregnancy And Fertility Testing
          1.3.1. Pregnancy Testing
          1.3.2. Fertility Testing
         1.4. Cholesterol Testing/Lipid Profiles
         1.5. Drugs-of-Abuse Testing
        2. Veterinary Diagnostics
        3. Food Safety And Environment Testing
        4. Drug Development And Quality Testing

  • 9.   Lateral Flow Assays Market, By Technique Historical Analysis and Forecast 2023-2031 (USD Million)

    •   1. Sandwich Assays
        2. Competitive Assays
        3. Multiplex Detection Assays

  • 10.   Lateral Flow Assays Market, By Sample Type Historical Analysis and Forecast 2023-2031 (USD Million)

    •   1. Blood Samples
        2. Urine Samples
        3. Saliva Samples
        4. Other Samples 

  • 11.   Lateral Flow Assays Market, By End User Historical Analysis and Forecast 2023-2031 (USD Million)

    •   1. Hospitals & Clinics
        2. Diagnostic Laboratories
        3. Home Care Settings
        4. Pharmaceutical & Biotechnology Companies
        5. Other End Users 

  • 12.   North America Lateral Flow Assays Market Analysis 2017-2022 and Forecast 2023-2031 (USD Million)

    •   1. Introduction
        2. Historical Market Size (USD Million) Analysis By Country, 2017-2022
         2.1. U.S.A
         2.2. Canada
         2.3. Mexico
        3. Market Size (USD Million) Forecast for North America 2023-2031

  • 13.   Latin America Lateral Flow Assays Market Analysis 2017-2022 and Forecast 2023-2031 (USD Million)

    •   1. Introduction
        2. Historical Market Size (USD Million) Analysis By Country, 2017-2022
         2.1. Brazil
         2.2. Venezuela
         2.3. Argentina
         2.4. Rest of Latin America
        3. Market Size (USD Million) Forecast for Latin America 2023-2031

  • 14.   Europe Lateral Flow Assays Market Analysis 2017-2022and Forecast 2023-2031 (USD Million)

    •   1. Introduction
        2. Historical Market Size (USD Million) Analysis By Country, 2017-2022
         2.1. Germany
         2.2. U.K
         2.3. France
         2.4. Italy
         2.5. Spain
         2.6. Russia
         2.7. Poland
         2.8. Rest of Europe
        3. Market Size (USD Million) Forecast for Europe 2023-2031

  • 15.   Asia Pacific Lateral Flow Assays Market Analysis 2017-2022 and Forecast 2023-2031 (USD Million)

    •   1. Introduction
        2. Historical Market Size (USD Million) Analysis By Country, 2017-2022
         2.1. Japan
         2.2. China
         2.3. India
         2.4. Australia and New Zealand
         2.5. ASEAN
         2.6. Rest of Asia Pacific
        3. Market Size (USD Million) Forecast for Asia Pacific 2023-2031

  • 16.   Middle East and Africa Market Analysis 2017-2022 and Forecast 2023-2031 (USD Million)

    •   1. Introduction
        2. Historical Market Size (USD Million) Analysis By Country, 2017-2022
         2.1. GCC
         2.2. Israel
         2.3. South Africa
         2.4. Rest of MEA
        3. Market Size (USD Million) Forecast for MEA 2023-2031

  • 17.   Market Share Analysis and Competitive Landscape
    •   1. Global Landscape - Key Players, Revenue and Presence
        2. Global Share Analysis - Key Players (Tier 1, Tier 2, Tier 3)
        3. Global Emerging Companies
        4. North America - Market Share Analysis and Key Regional Players
        5. Europe - Market Share Analysis and Key Regional Players
        6. Asia Pacific - Market Share Analysis and Key Regional Players
        7. Global Key Player - Growth Matrix
  • 18.   Company Profiles (Competition Dashboard, Competitors Deep Dive, Products Offered and Financial Layouts)

    •   1. Abbott Laboratories
         1.1. Company Overview
         1.2. Product Portfolio
         1.3. SWOT Analysis
         1.4. Financial Overview
         1.5. Strategic Overview
        2. F. Hoffman-La Roche Ltd.
         2.1. Company Overview
         2.2. Product Portfolio
         2.3. SWOT Analysis
         2.4. Financial Overview
         2.5. Strategic Overview
        3. Danaher Corporation
         3.1. Company Overview
         3.2. Product Portfolio
         3.3. SWOT Analysis
         3.4. Financial Overview
         3.5. Strategic Overview
        4. Siemens AG
         4.1. Company Overview
         4.2. Product Portfolio
         4.3. SWOT Analysis
         4.4. Financial Overview
         4.5. Strategic Overview
        5. Becton, Dickinson and Company
         5.1. Company Overview
         5.2. Product Portfolio
         5.3. SWOT Analysis
         5.4. Financial Overview
         5.5. Strategic Overview
        6. bioMérieux SA
         6.1. Company Overview
         6.2. Product Portfolio
         6.3. SWOT Analysis
         6.4. Financial Overview
         6.5. Strategic Overview
        7. Bio-Rad Laboratories
         7.1. Company Overview
         7.2. Product Portfolio
         7.3. SWOT Analysis
         7.4. Financial Overview
         7.5. Strategic Overview
        8. Thermo Fisher Scientific, Inc.
         8.1. Company Overview
         8.2. Product Portfolio
         8.3. SWOT Analysis
         8.4. Financial Overview
         8.5. Strategic Overview
        9. PerkinElmer Inc.
         9.1. Company Overview
         9.2. Product Portfolio
         9.3. SWOT Analysis
         9.4. Financial Overview
         9.5. Strategic Overview
        10.Hologic Inc.
         10.1. Company Overview
         10.2. Product Portfolio
         10.3. SWOT Analysis
         10.4. Financial Overview
         10.5. Strategic Overview
        11.QIAGEN N.V.
         11.1. Company Overview
         11.2. Product Portfolio
         11.3. SWOT Analysis
         11.4. Financial Overview
         11.5. Strategic Overview
        12.Quidel Corporation
         12.1. Company Overview
         12.2. Product Portfolio
         12.3. SWOT Analysis
         12.4. Financial Overview
         12.5. Strategic Overview
        13.Merck KGaA
         13.1. Company Overview
         13.2. Product Portfolio
         13.3. SWOT Analysis
         13.4. Financial Overview
         13.5. Strategic Overview
        14.Abcam plc.
         14.1. Company Overview
         14.2. Product Portfolio
         14.3. SWOT Analysis
         14.4. Financial Overview
         14.5. Strategic Overview
        15.Surmodics IVD
         15.1. Company Overview
         15.2. Product Portfolio
         15.3. SWOT Analysis
         15.4. Financial Overview
         15.5. Strategic Overview
        16.Chembio Diagnostic Systems, Inc.
         16.1. Company Overview
         16.2. Product Portfolio
         16.3. SWOT Analysis
         16.4. Financial Overview
         16.5. Strategic Overview
        17.OraSure Technologies
         17.1. Company Overview
         17.2. Product Portfolio
         17.3. SWOT Analysis
         17.4. Financial Overview
         17.5. Strategic Overview
        18.DCN Diagnostics
         18.1. Company Overview
         18.2. Product Portfolio
         18.3. SWOT Analysis
         18.4. Financial Overview
         18.5. Strategic Overview
        19.Polysciences, Inc.
         19.1. Company Overview
         19.2. Product Portfolio
         19.3. SWOT Analysis
         19.4. Financial Overview
         19.5. Strategic Overview
        20.Abingdon Health
         20.1. Company Overview
         20.2. Product Portfolio
         20.3. SWOT Analysis
         20.4. Financial Overview
         20.5. Strategic Overview
        21.BioPorto Diagnostics A/S
         21.1. Company Overview
         21.2. Product Portfolio
         21.3. SWOT Analysis
         21.4. Financial Overview
         21.5. Strategic Overview
        22.Microcoat Biotechnologie GmbH.
         22.1. Company Overview
         22.2. Product Portfolio
         22.3. SWOT Analysis
         22.4. Financial Overview
         22.5. Strategic Overview
        23.Scienion AG
         23.1. Company Overview
         23.2. Product Portfolio
         23.3. SWOT Analysis
         23.4. Financial Overview
         23.5. Strategic Overview
        24.Senova GmbH
         24.1. Company Overview
         24.2. Product Portfolio
         24.3. SWOT Analysis
         24.4. Financial Overview
         24.5. Strategic Overview
        25.Access Bio, Inc.
         25.1. Company Overview
         25.2. Product Portfolio
         25.3. SWOT Analysis
         25.4. Financial Overview
         25.5. Strategic Overview

  • 19.   Pre and Post COVID-19 Impact
    •   1. Positive influence on the healthcare industry
        2. The financial disruption of the manufacturing sector
        3. Impact of COVID-19 on emerging companies
        4. Significant mandates in the healthcare regulations initiated by administrations
        5. The overall economic slowdown of the developing and developed nations
  • 20.   FutureWise SME Key Takeaway Points for Client

Ask for Discount
Buy Now
Customize This Report
  • We Offer Special Discounts for start-ups, NGOs, and Educational & Research institutions.

Need Assistance

  • UK : +44 141 628 9353
  • US : +1 347 709 4931

What you get

  • Excel Dataset
  • Market Overview
  • Infographics
  • PowerPoint Presentation
  • PDF Report

What's included

  • Consumer Perception and Procurement
  • Market Data Forecast
  • Competitive Analysis
  • Risks and Opportunity Assessment
  • Market Trends and Dynamics
Partner

Our Clients

image0
image1
image2
image3
image4
image5
image6
image7
image8
image9
image10
image11
image11
image11
image11
image11
image11
image11
image11
image11
image11
image11
image11
image11
image11
image11